0B68 Kasner, Margaret Thea - Thomas Jefferson University - Thomas Jefferson University
Dr. Kasner

Margaret T. Kasner, MD

Contact Dr. Kasner

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Acute myeloid leukemia patients’ clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein exp 16BF ression in leukemic blasts
  2. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  3. Polo-like kinase and its inhibitors: Ready for the match to start?
  4. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  5. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors
  6. Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation
  7. Treatment of adult ALL: More questions than answers
  8. Treatment of adult ALL: more questions than answers.
  9. Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy
  10. A2-step approach to myeloablative haploidentical stem cell transplantation: A phase 1/2 trial performed with optimized T-cell dosing
  11. Novel targets for treatment of adult acute lymphocytic leukemia
  12. A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia
  13. Update on the therapy for myelodysplastic syndrome
  14. Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality
  15. Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia
0